Stock Events

Stock Events

Ionis Pharmaceuticals 

$75.25
79
-$0.2-0.27% Tuesday 20:00

Statistics

Day High
76.86
Day Low
74.83
52W High
86.5
52W Low
31.71
Volume
850,246
Avg. Volume
-
Mkt Cap
12.43B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-1.41
-0.71
-0
0.7
Expected EPS
-1.032353
Actual EPS
N/A

Financials

-40.41%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.89BRevenue
-762.77MNet Income

Analyst Ratings

107.73Average Price Target
The highest estimate is 130.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
91%
Hold
9%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IONS. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alnylam Pharmaceuticals
ALNY
Mkt Cap39.51B
Alnylam Pharmaceuticals specializes in RNAi therapeutics, directly competing with Ionis in the genetic disorder treatment space.
Biogen
BIIB
Mkt Cap27.62B
Biogen collaborates with Ionis on Spinraza but also competes in developing treatments for neurological disorders.
Moderna
MRNA
Mkt Cap17.99B
Moderna's focus on mRNA technology for drug development places it in competition with Ionis's antisense technology.
Sarepta Therapeutics
SRPT
Mkt Cap2.27B
Sarepta Therapeutics competes in the development of genetic treatments, particularly for Duchenne muscular dystrophy, overlapping with Ionis's target areas.
Vertex Pharmaceuticals
VRTX
Mkt Cap107.83B
Vertex Pharmaceuticals competes in the cystic fibrosis market, where Ionis also has interests through its drug development efforts.
Arrowhead Pharmaceuticals
ARWR
Mkt Cap10.48B
Arrowhead Pharmaceuticals focuses on RNAi therapeutics for treating chronic diseases, competing with Ionis in the RNA space.
PTC Therapeutics
PTCT
Mkt Cap5.43B
PTC Therapeutics focuses on the discovery and commercialization of novel medicines, including for genetic disorders, competing with Ionis.

About

There is no Profile data available for ISI.SG.
Show more...
CEO
Dr. Brett P. Monia Ph.D.
Employees
1069
Country
United States
ISIN
US4622221004

Listings

MI
IT
1IONS.MI
MU
DE
ISI.MU
STU
DE
ISI.STU
MX
MX
IONS.MX

0 Comments

Share your thoughts

FAQ

What is Ionis Pharmaceuticals stock price today?▼
The current price of IONS is $75.25 USD — it has decreased by -0.27% in the past 24 hours. Watch Ionis Pharmaceuticals stock price performance more closely on the chart.
What is Ionis Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ionis Pharmaceuticals stocks are traded under the ticker IONS.
Is Ionis Pharmaceuticals stock price growing?▼
IONS stock has risen by +0.56% compared to the previous week, the month change is a +1.24% rise, over the last year Ionis Pharmaceuticals has showed a +136.19% increase.
What is Ionis Pharmaceuticals market cap?▼
Today Ionis Pharmaceuticals has the market capitalization of 12.43B
When is the next Ionis Pharmaceuticals earnings date?▼
Ionis Pharmaceuticals is going to release the next earnings report on August 05, 2026.
What were Ionis Pharmaceuticals earnings last quarter?▼
IONS earnings for the last quarter are -0.56 USD per share, whereas the estimation was -0.88 USD resulting in a +36.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Ionis Pharmaceuticals revenue for the last year?▼
Ionis Pharmaceuticals revenue for the last year amounts to 1.89B USD.
What is Ionis Pharmaceuticals net income for the last year?▼
IONS net income for the last year is -762.77M USD.
How many employees does Ionis Pharmaceuticals have?▼
As of May 06, 2026, the company has 1,069 employees.
In which sector is Ionis Pharmaceuticals located?▼
Ionis Pharmaceuticals operates in the Health & Wellness sector.
When did Ionis Pharmaceuticals complete a stock split?▼
Ionis Pharmaceuticals has not had any recent stock splits.
Where is Ionis Pharmaceuticals headquartered?▼
Ionis Pharmaceuticals is headquartered in Carlsbad, United States.